Differential effects of membrane cholesterol content on the transport activity of multidrug resistance - Associated protein 2 (ABCC2) and of the bile salt export pump (ABCB11)

Molecular Pharmacology

Volumn 85, Issue 6, 2014, Pages 909-920

  Guyot, Christelle ^a   Hofstetter, Lia ^a   Stieger, Bruno ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT EXPORT PUMP; CHOLECYSTOKININ OCTAPEPTIDE; CHOLESTEROL; ESTRADIOL; GLUCURONIDE; GLUTATHIONE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; OCHRATOXIN; VASOPRESSIN;

ARTICLE; BACULOVIRUS; BINDING SITE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; INSECT CELL; MICHAELIS MENTEN KINETICS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS;

ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; CHOLESTEROL; HUMANS; KINETICS; MEMBRANE LIPIDS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 84899561905     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.092262     Document Type: Article

References (54)

1. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, and Urbatsch IL et al. (2009) Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323:1718-1722.
2. Bligh EG and Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
3. Bodo A, Bakos E, Szeri F, Varadi A, and Sarkadi B (2003) Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J Biol Chem 278:23529-23537.
4. Borst P, Zelcer N, and Van De Wetering K (2006) MRP2 and 3 in health and disease. Cancer Lett 234:51-61.
5. Bossard R, Stieger B, O'Neill B, Fricker G, and Meier PJ (1993) Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 91:2714-2720.
6. Cornelius F, Mahmmoud YA, and Christensen HR (2001) Modulation of Na, K-ATPase by associated small transmembrane regulatory proteins and by lipids. J Bioenerg Biomembr 33:415-423.
7. Dawson S, Stahl S, Paul N, Barber J, and Kenna JG (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40:130-138.
8. Dermauw W and Van Leeuwen T (2014) The ABC gene family in arthropods: comparative genomics and role in insecticide transport and resistance. Insect Biochem Mol Biol 45:89-110.
9. De Waart DR, Paulusma CC, Kunne C, and Oude Elferink RP (2006) Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int 26:362-368.
10. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, and Meier PJ (1998) The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273:10046-10050.
11. Gimpl G, Klein U, Reiländer H, and Fahrenholz F (1995) Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry 34:13794-13801.
12. Guyot C and Stieger B (2011) Interaction of bile salts with rat canalicular membrane vesicles: evidence for bile salt resistant microdomains. J Hepatol 55:1368-1376.
13. Hazard SE and Patel SB (2007) Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols. Pflugers Arch 453:745-752.
14. Hirono S, Nakagome I, Imai R, Maeda K, Kusuhara H, and Sugiyama Y (2005) Estimation of the three-dimensional pharmacophore of ligands for rat multidrugresistance-associated protein 2 using ligand-based drug design techniques. Pharm Res 22:260-269.
15. Ismair MG, Häusler S, Stuermer CA, Guyot C, Meier PJ, Roth J, and Stieger B (2009) ABC-transporters are localized in caveolin-1-positive and reggie-1-negative and reggie-2-negative microdomains of the canalicular membrane in rat hepatocytes. Hepatology 49:1673-1682.
16. Ito K, Hoekstra D, and Van Ijzendoorn SC (2008) Cholesterol but not association with detergent resistant membranes is necessary for the transport function of MRP2/ABCC2. FEBS Lett 582:4153-4157.
17. Kimura Y, Kioka N, Kato H, Matsuo M, and Ueda K (2007a) Modulation of drugstimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. Biochem J 401:597-605.
18. Kimura Y, Kodan A, Matsuo M, and Ueda K (2007b) Cholesterol fill-in model: mechanism for substrate recognition by ABC proteins. J Bioenerg Biomembr 39:447-452.
19. Kis E, Ioja E, Nagy T, Szente L, Herëdi-Szabó K, and Krajcsi P (2009) Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors. Drug Metab Dispos 37:1878-1886.
20. Kopplow K, Letschert K, König J, Walter B, and Keppler D (2005) Human hepatobiliary transport of organic anions analyzed by quadruple- transfected cells. Mol Pharmacol 68:1031-1038.
21. Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, and Pauli-Magnus C (2007) Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 17:47-60.
22. Leier I, Hummel-Eisenbeiss J, Cui Y, and Keppler D (2000) ATP-dependent paraaminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int 57:1636-1642.
23. Madon J, Hagenbuch B, Landmann L, Meier PJ, and Stieger B (2000) Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 57:634-641.
24. Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ, and Stieger B (2006) Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 44:62-74.
25. Meier PJ, Sztul ES, Reuben A, and Boyer JL (1984) Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J Cell Biol 98:991-1000.
26. Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick GA, Meier PJ, Stieger B, and Pauli-Magnus C (2008) Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T. C polymorphism in the bile salt export pump. World J Gastroenterol 14:38-45.
27. Morgan RE, Trauner M, Van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Jr, Lightfoot-Dunn R, and Hamadeh HK (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118:485-500.
28. Neet KE (1980) Cooperativity in enzyme function: equilibrium and kinetic aspects. Methods Enzymol 64:139-192.
29. Nies AT and Keppler D (2007) The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 453:643-659.
30. Noe J, Kullak-Ublick GA, Jochum W, Stieger B, Kerb R, Haberl M, Müllhaupt B, Meier PJ, and Pauli-Magnus C (2005) Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. J Hepatol 43:536-543.
31. Noë J, Stieger B, and Meier PJ (2002) Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 123:1659-1666.
32. Oude Elferink RP and Paulusma CC (2007) Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch 453:601-610.
33. Pauli-Magnus C, Kerb R, Fattinger K, Lang T, Anwald B, Kullak-Ublick GA, Beuers U, and Meier PJ (2004) BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 39:779-791.
34. Pauli-Magnus C, Meier PJ, and Stieger B (2010) Genetic determinants of druginduced cholestasis and intrahepatic cholestasis of pregnancy. Semin Liver Dis 30:147-159.
35. Paulusma CC, De Waart DR, Kunne C, Mok KS, and Elferink RP (2009) Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content. J Biol Chem 284:9947-9954.
36. Perez MJ and Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15:1677-1689.
37. Reid G, Wielinga P, Zelcer N, Van Der Heijden I, Kuil A, De Haas M, Wijnholds J, and Borst P (2003) The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA 100:9244-9249.
38. Roda A, Cerrë C, Fini A, Sipahi AM, and Baraldini M (1995) Experimental evaluation of a model for predicting micellar composition and concentration of monomeric species in bile salt binary mixtures. J Pharm Sci 84:593-598.
39. Rouser G, Fkeischer S, and Yamamoto A (1970) Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496.
40. Sasaki M, Suzuki H, Ito K, Abe T, and Sugiyama Y (2002) Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2). J Biol Chem 277:6497-6503.
41. Schrickx J, Lektarau Y, and Fink-Gremmels J (2006) Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch Toxicol 80:243-249.
42. Shinoda T, Ogawa H, Cornelius F, and Toyoshima C (2009) Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 459:446-450.
43. Small DM (2003) Role of ABC transporters in secretion of cholesterol from liver into bile. Proc Natl Acad Sci USA 100:4-6.
44. Stieger B (2010) Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metab Rev 42:437-445.
45. Stieger B (2011) The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handbook Exp Pharmacol 201:205-259.
46. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, and Meier PJ (2000) Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118:422-430.
47. Stieger B, Hagenbuch B, Landmann L, Höchli M, Schroeder A, and Meier PJ (1994) In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107:1781-1787.
48. Stieger B, Meier Y, and Meier PJ (2007) The bile salt export pump. Pflugers Arch 453:611-620.
49. Szeri F, Iliás A, Pomozi V, Robinow S, Bakos E, and Váradi A (2009) The high turnover Drosophila multidrug resistance-associated protein shares the biochemical features of its human orthologues. Biochim Biophys Acta 1788:402-409.
50. Telbisz A, Hegedüs C, Váradi A, Sarkadi B, and Ozvegy-Laczka C (2014) Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites. Drug Metab Dispos 42:575-585.
51. Telbisz A, Müller M, Ozvegy-Laczka C, Homolya L, Szente L, Váradi A, and Sarkadi B (2007) Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. Biochim Biophys Acta 1768:2698-2713.
52. Trauner M, Fickert P, Halilbasic E, and Moustafa T (2008) Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases. Wien Med Wochenschr 158:542-548.
53. Utanohara S, Tsuji M, Momma S, Morio Y, and Oguchi K (2005) The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. Toxicology 214:77-86.
54. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscheer P, Schellens JH, Schinkel AH, and Borst P (2003) Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 278:23538-23544.